Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current topics in pulmonary oncology]

J P Sculier1, T Berghmans, P Vermylen

  • 1Service de Médecine, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles.

Revue Medicale De Bruxelles
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group.

Lung cancer (Amsterdam, Netherlands)·2025
Same author

[Non-small cell lung cancer in adults under 40 years of age].

Revue des maladies respiratoires·2024
Same author

[Severe complications of systemic treatment in thoracic oncology].

Revue des maladies respiratoires·2024
Same author

[Olimetastatic disease: Current status and perspectives in non-small cell lung cancer].

Revue des maladies respiratoires·2023
Same author

Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial.

ESMO open·2023
Same author

[Respiratory cancer diseases: Which role for intensive care ?]

Revue des maladies respiratoires·2023

Advancements in thoracic oncology, including new diagnostic tools and chemotherapy, are improving lung cancer treatment outcomes. A multidisciplinary approach is crucial for managing complex cases.

Area of Science:

  • Oncology
  • Pulmonology
  • Medical Diagnostics

Context:

  • Thoracic oncology is rapidly evolving with new diagnostic and therapeutic modalities.
  • Early detection of lung cancer is enhanced by tools like photodetection, enabling localized treatment.
  • Current treatments for advanced lung cancer, including chemotherapy and radiotherapy, show improved survival rates.

Purpose:

  • To summarize recent advancements in thoracic oncology and their impact on lung cancer management.
  • To highlight the evolving landscape of lung cancer diagnosis and treatment strategies.
  • To emphasize the necessity of a multidisciplinary approach in thoracic oncology.

Summary:

  • Novel diagnostic techniques, such as photodetection, allow for the identification of preneoplastic lesions and early-stage lung cancers.

Related Experiment Videos

  • Photochemotherapy, cryotherapy, and brachytherapy offer localized treatment options for early-stage thoracic malignancies.
  • Cisplatin-based chemotherapy demonstrates survival benefits for patients with Stage III and IV non-small cell lung cancer.
  • Emerging strategies for small cell lung cancer include accelerated chemotherapy, early chest radiotherapy, and maintenance therapy.
  • The identification of new cytotoxic agents further expands therapeutic options for lung cancer patients.

    • Impact:

    • Improved diagnostic capabilities leading to earlier intervention and potentially better prognoses.
    • Enhanced treatment efficacy for both early and advanced stages of lung cancer.
    • The growing complexity of lung cancer care necessitates an integrated, multidisciplinary team approach for optimal patient outcomes.